undefined

Lars Fruergaard Jørgensen

CEO of Novo Nordisk, a leading global pharmaceutical company focused on diabetes and obesity treatments. Known for his insights on the complexities of obesity and the company's innovative approach to healthcare.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app